Content continues after advertisement

Research Note: Pregabalin in the Treatment of Neuropathic Pain


December 2019

Sign in to Print/View PDF

This double-masked, randomized, crossover, placebo-controlled clinical trial evaluated the use of pregabalin in 8 dogs that had neuropathic pain associated with Chiari-like malformations and syringomyelia. Each dog underwent a placebo and a pregabalin treatment phase. Using a numerical scale, owners reported improved daily pain scores when dogs were treated with pregabalin. Pregabalin also significantly improved quantitative sensory testing, including mechanical hyperalgesia, cold hyperalgesia at 32°F (0°C), and cold allodynia at 59°F (15°C). In addition to its efficacy, pregabalin was well tolerated and noncumulative and had few adverse effects other than mild sedation.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2022 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy